A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)

Clinical trial NCT07621237 · RECRUITING

Trial details

NCT number: NCT07621237
Sponsor: Tonix Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Episode (MDE)Major Depressive Disorder (MDD)Depression

Start date: 2026-06-01
Primary completion: 2028-02-01
Enrollment: 360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.